Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Finland
Sweden
Denmark
Norway
Latest
Trending
Followed

Arjo, Audiocast with teleconference, Q3'24

By Inderes10/17/2024, 6:00 AM
Arjo

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Joacim Lindoff
00:00 - 03:55

Very much appreciated, and also from our side. Welcome to Arjo's Q3 2024 earnings call, where Niclas and I look forward to giving you some details on the Q3 report. Next slide please. We'll start with a business update from Q3, a financial update, and our outlook for 2024 before we open up for questions. And as always, we intend to keep this call to an hour and be ready by 9:00. Next slide, please. At the time of the Q2 report, we talked about a slightly uncertain situation for capital sales in Europe due to political uncertainty in some of our major markets. This uncertainty has resulted in lower than expected capital sales in Europe in the quarter. In addition, we saw some unexpected shortfalls in China and Japan. Also on the capital side in the quarter, and in total, we therefore report only a 1.5% organic growth in the quarter, which is around 2 to 2.5 percentage points lower than our expectations that we had when we spoke last time at the beginning of Q3. On the positive side, we have a solid order intake on capital and also good development of our service and rental business, which gives us stability for the coming quarters. But with low visibility into the European market for capital, we currently see that we will have to navigate these circumstances for quite some quarters to come. A gross margin came in at 42%, an improvement versus Q3 of 2023 despite the current headwinds. The lower capital sales, down approximately 40 million SEK in comparable currencies and more in volume versus last year, are generating a negative mix effect and lower absorption in our factories. And this is a trend that we will continue to see as long as our capital sales remain on the weaker side. In addition, we experienced a significant negative transaction effect from currency fluctuations. And altogether, these effects are the main headwinds on gross margin for the quarter. Our current activities around price adjustments, internal efficiency, and product mix continue to generate results and are compensating for the higher cost levels driven mainly by salaries. We see risk for continued weaker capital market in Europe over the coming quarters, and we will therefore need to accelerate our efficiency activities in both cost of goods sold and OpEx to safeguard our profitability development. On OpEx in the quarter, I think it's fair to say that we have continued to have good cost control throughout the organization, and OpEx as a percentage of net sales is so far stable compared to last year, despite the high inflationary salary increases and lower than expected net sales development. Adjusted EBITDA decreased to 434 million. Second quarter adjusted EBIT decreased to 164 million versus 186 in Q3 of 2023, impacted by lower capital sales and significant negative currency effects, totaling a negative delta of -34 million versus last year. Operationally, we are trending better on EBIT, but the lower than expected capital sales could not compensate for the significant drop in currency at this time. Our operational cash flow for Q3 was 437 million, leading to a cash conversion of 102% for the quarter, and we are well aligned with our target for the full year of at least 80%. Niclas will take you through further details in his part. I'm also happy to inform you that Maria Fagerberg will join us as the new EVP for Strategy no later than the 7th of January, 2025.

Unknown 1
03:55 - 03:56

And.

Joacim Lindoff
03:56 - 05:53

We have a solid interim setup in place until she joins. Maria comes with extensive Q3 background within MedTech, and will, with her track record, be a very good addition to our leadership team. I am also very pleased to announce that Una Droga has decided to stay with Arjo in her role as EVP for Supply Chain and Operations. A decision that creates continued stability in our work to optimize our supply chain and operations efforts throughout the group. In summary, Q3 was a quarter where we, despite a lower trend in capital sales in Europe and some countries in the rest of the world, managed to grow the group organically by 1.5%. Our business in Canada continues to grow. The US starts to show signs of recovery in capital sales, and our rental and service business develops well globally. The end of the quarter saw improved development in both order intake and capital sales in July and August. However, there is headwind and diminished visibility for capital sales, particularly in Europe, for the upcoming quarters. And we will make sure that we navigate this situation well going forward. Next slide, please. North America grew by 2.4% organically in the quarter and is now up by 4.9% on organic net sales after the first three quarters. Canada had a good quarter with rental, service, and capital all developing according to plan. We continue to grow our market presence in Canada, and I foresee that Canada will continue to be a very important market for us also over the coming years, both driven by needed investments into the Canadian health system and obviously good internal work. The positive trend in the US continues. Healthcare providers are step by step strengthening their financials. And with that comes also a gradual improvement in capital.

Unknown 1
05:53 - 05:54

Investments.

Joacim Lindoff
05:54 - 10:38

As previously mentioned, the nature of our business does not put us first in line for these investments, which in the first phase go more towards processes in the operating room. But we are now starting to see better momentum toward our projects and solutions. DVT continues to be a drag on organic growth due to the previously signaled price pressure and loss of customers. Because of that, we have seen this development in Q1 and Q2 as well, only in Q3. We have lost approximately 2 million USD and expect that to be the case in Q4 and in Q1 of 2025 as well. Meanwhile, for most of 2025, we expect this trend to have bottomed out, and we are anticipating a return to growth in this area from Q2 of 2025 onwards. As before, our service and rental business in the US continues to maintain positive momentum, especially in rentals. We foresee this trend to continue as we have now secured additional customer implementations. It is also good to see that our transactional patient handling sales are developing well, with one of the drivers being our air-assisted business, where the product range from the acquisition of Air Pal is developing above plan. The development of transactional sales is especially good in acute care, where both long-term care and government sales have yet to pick up to reach the expected levels, even though the quarter, as expected, was low. In regards to outcome programs, we are now realistically looking at a Q4 where we believe that we will return to the needed pace in this area. My previous mention of further stability in the financial situation of healthcare in the US is the main driver, and we expect this to develop step by step also for the coming quarters. Overall, a solid quarter in North America with potential, especially in the US, to develop the organic net sales in the quarters to come. Next slide please. Moving over to our global sales region, where the net sales declined somewhat compared to last year's Q3. Western Europe was down by half a percent in the quarter. On organic net sales, we continue to have good clinical demand for our products and solutions. But decision-making has been significantly more volatile in countries like France, the Netherlands, and the UK, leading to lower capital volumes. We continue to see strong development in both service and rental, which are performing slightly better than forecast in this area. We have talked about the uncertainties around capital spend levels in European healthcare in previous teleconferences, and for Q3 that has been clearly visible. Our pipeline is good and growing. We do not see a loss of market shares in any of our main markets, but we continue to see postponements and delays of capital expenditure decisions based on our current information. And this is something that we believe we will have to continue to navigate for some quarters to come. It is still encouraging to see the long-term commitment from both the UK and France to invest in solving the large-scale problems facing healthcare, around demographic change and the need for more efficient care of patients. But it is clear that financial deficits will be a headwind for us to navigate in the short term. Also, countries like Germany, the restructuring of healthcare will give some short term bumps in the road, but we feel positive about the possibilities moving forward in a market where we are already well established. Our diagnostics business grew compared to low comparables in the quarter. Also, in this area. Given the dependency on the UK in particular, we are performing lower than forecast and expect this to continue throughout Q4. We do expect to see a quite satisfactory growth in this area going forward, but again, from a low base in 2023, and we still have work to be done to get net sales to where we expect them to be, given our product lineup and overall offering. In summary, for Western Europe, there is continued good momentum in rental and service, with a pipeline that continues to grow, but there is lower visibility on capital spending. The latter part of the quarter was better than July and August, but we will remain very focused when navigating this environment in the quarters to come. Next slide.

Unknown 1
10:38 - 10:39

Please.

Joacim Lindoff
10:40 - 13:47

Moving over to the rest of the world, then, where Q3 saw organic growth of 2.5%. Australia, India, and South Africa. Three important markets in this region continue to see positive momentum and growth, with capital, service, and rental growing. Our business in Singapore was lower than last year due to some large projects in Q3 of 2023, but it is developing well and aligned with plans overall. The big disappointment in the quarter in the rest of the world was China, where we saw some good capital projects in Q3 last year, but this year in Q3, we have experienced an almost dried-up capital projects market. Based on information standards as of today, we believe that these low activity levels will continue for some time in China, and we will have to adapt to this significantly lower capital spend environment. From an internal perspective, Japan also experienced a decline compared to last year. But this is, in our view, mainly due to a delay in our shift of business model, and we feel comfortable that we will be on a growth track in Japan in the quarters to come. The significant EU funding to Poland, with large amounts being allocated to the refurbishment of healthcare, has been slightly delayed compared to expectations by the end of Q2. This has caused what we define as a tsunami effect, where very few capital investments have been made in Q3 in anticipation of the investment funds, but we are expecting a significant inflow of projects in Q4 that will have a major effect in 2025 and 2026. We are well positioned to gain good market shares of these products, which is obviously very good for the long term. Next slide, please. The improvement journey on profitability continues, and gross margin improved to 42% for the quarter versus 41.4% in Q3 of 2023, an improvement yet lower than forecast after the end of Q2, mainly due to lower capital volumes affecting both mix and supply chain utilization, but also significant impact from negative transaction currency effects. As in previous quarters, we have faced higher salary costs in supply chain, rental, and service, which we have mitigated through continued work on internal efficiency and a sustained focus on price alignment, something that we expect will also continue in the coming quarters. And as discussed also in the Q2 teleconference, our forecast is that we will see price adding between 1 to 1.5% growth on the top line for the full year, and we are currently trending at around 1% after Q3. Given the low visibility on capital spend in Europe, this situation is obviously concerning.

Unknown 1
13:47 - 13:47

The.

Joacim Lindoff
13:47 - 15:45

Significant fine-tuning is ongoing in this area from a category perspective. We have continued to perform well on patient handling, maintaining a strong gross margin, and with additional traction in this category, we expect to see a continued improvement of our product mix over time. Service sees slightly weaker margins in Q3 compared to Q3 of 2023, but this is almost solely due to negative currency effects. And we also continue to improve our gross margin in rental. Despite the high pressure on salary costs, transportation costs came in higher than expected compared to last year. The continued pressure from the situation in the Middle East and harbor strikes in the US will continue to be a smaller negative in our comparisons also into Q4, both versus forecast and last year. We expect to see negative effects from the lower capital equipment sales also in Q4, on top of the already committed efficiency projects in the supply chain and continued work with pricing. We will accelerate efficiency programs further to be able to navigate to a lower short-term capital development. Extensive work is ongoing to further detail these activities, and we are confident that we will have solid plans in place effective beginning of 2025. Next slide please. OpEx continues to be well managed within the group, and we are seeing an increase of 2.3% or $23 million in comparable currencies despite significant salary inflation on these lines. OpEx as a percentage of net sales grew slightly in the quarter, on par for the full year, mainly due to the higher than expected or lower than expected capital net sales development. We continue to drive initiatives for profitable sales development as before.

Unknown 1
15:45 - 15:46

But.

Joacim Lindoff
15:46 - 16:51

We will actively review structures in OpEx where we are experiencing lower demand than planned in R&D. Gross investment is trending at almost 3% for the quarter, which is, as before, aligned with our product development plans. And as stated also after Q2, we are planning for larger launches in hygiene at the end of this year and interesting launches in pressure injury prevention and patient handling at the beginning of 2025. The main factors impacting adjusted EBIT this quarter are total negative currency effects and revaluation of our accounts receivables and accounts payable of -$34 million, and obviously the lower than expected capital sales. And we obviously also saw the same factors impacting adjusted EBITDA. Restructuring came in slightly lower than expected in the quarter, and we are still trending towards the indicated approximately 45 million for the full year. Next slide please. And here I would like to hand over to Niclas.

Unknown 1
16:51 - 16:51

Thank you.

Niclas Sjöswärd
16:51 - 20:16

Joacim. And good morning from my side as well. The operational cash flow improved sequentially in quarter three versus quarter two, but is down compared to quarter three last year due to a difficult comparison with the strong release from higher-than-normal inventory last year, which is not repeated this year due to more balanced inventory levels. Working capital improved in the quarter, resulting from good work with all parts, including inventory, accounts receivable, and accounts payable. Our long-term improvement activities regarding working capital are continuing to pay off, and this focus will, of course, continue. Working Capital Days saw a significant improvement year over year in the quarter, down to 78 days compared to quarter three last year, which was 86 days. It's also sequentially down from Quarter 2, which had 79 days. The improved working capital provides a stable operating cash flow of 437 million, sequentially up from 344 million in quarter two. The operating cash flow for quarter three last year was 565 million, mainly driven by the strong release of higher-than-normal inventory levels I mentioned before. Cash conversion improved sequentially to 102%, versus 70% in the second quarter. We are well on track toward our target of 80% cash conversion for the full year. And for your information, cash flow from investing activities was -190 million versus -134 million in quarter three last year, mainly consisting of investments in our rental fleet, product development, and fixed assets, but also includes the payment for the GerroMed acquisition made this quarter. Next slide please. Our net debt is down year over year from $4.7 billion in quarter three last year to $4.4 billion in this quarter. Sequentially, the $4.4 billion net debt is also down versus the $4.5 billion in quarter two. Our financial net, as well as our interest net, have decreased compared to the same period last year, and this is mainly connected to our lower funding costs and reduced interest rates. We expect our reduction journey on net debt to continue in the coming quarters and, together with lower interest rates during the rest of 2024, we now see decreased financial costs throughout the year. Our cash position remains strong. Our leverage net debt to adjusted EBITDA improved year over year and came in at 2.2 in this quarter versus the 2.6 in Q3 last year. This is a consequence of last year's activities regarding improved profitability. Our focus on working capital and cash flow. Sequentially, the leverage is also down versus the 2.4 in Q2. And for your information, 2.2 is the lowest leverage since the Spin-Off. Equity ratio came in at 50.2%, which is a small increase from the 50.1% last quarter. Then I hand back over to you, Joacim. Next slide please.

Joacim Lindoff
20:18 - 21:19

Thanks, Niklas. Um, as you know, we made two smaller acquisitions in the quarter. GerroMed in Germany is a good example of what we look for. In the first of our three M&A buckets, we focus on strengthening our footprint in rental and service. Tech Med has a clear market expansion possibility for our diagnostics business and also fits well into both overall strategy and M&A focus. These two small acquisitions will generate smaller positive effects for Arjo from 2025, and again, are good examples of targets that were in contact with. Next slide please. Shortly, our outlook for 2024, based on the information we have today, is still forecasted to be within our target interval of 3 to 5% in organic net sales, despite the slowdown in capital sales, mainly in Europe. Next slide.

Unknown 1
21:19 - 21:19

Please.

Joacim Lindoff
21:21 - 23:11

With that, I would like to summarize today's call. We closed Q3 with a 1.5% organic growth, which is lower than expectations due to lower capital sales in some European markets and also in a few of the rest of the world markets. The low visibility on decision-making around capital equipment sales, particularly in Europe, is expected to persist for some time, and we will need to continue navigating the situation effectively and attentively. We continue our improvement journey on gross margin despite headwinds from lower capital sales and negative currency effects, and we continue to manage our operating expenses in a good way. Apart from the lower capital sales, currency is also affecting EBIT, with approximately a negative 34 million versus Q3 of 2023. Our profitability journey, excluding currency, continues, but we obviously have to adapt cost structures for all effects going forward. We continue to do solid work around our cash flow, and as a result of that and other activities, we register 2.2 as leverage, which, as Niclas said, is the lowest level for Arjo since the spinoff. We now enter into Q4 with a continued high activity level, where we will need to navigate a lower visibility around capital sales. We still estimate that we can reach our outlook for 3 to 5% organic growth for the full year. And finally, I would like to let you know and inform you about that. We will host a capital markets update in Stockholm in conjunction with the release of our Q4 report on January 30, 2025. More information will follow on this as we get closer. With that, we can open up for questions. Moderator.

Operator
23:15 - 23:42

If you wish to ask a question, please dial pound key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial Pound Key six on your telephone keypad. The next question comes from David Johansson from Nordic Markets. Please go ahead.

Unknown 2
23:46 - 24:26

Hi. Good morning. Thank you for taking my questions. I want to focus a bit on Western Europe. I think, you know, listening to your comments around weakness in capital goods at the beginning of the quarter, but perhaps ending on a higher note, do you anticipate a bounce back now for Q4, or should we expect these markets to remain at a lower level due to this capital goods weakness? Your experience? I mean, your comment on political isolation having an impact suggests expecting almost a structural weakness here for some time. Is this something that you're seeing, or is this more likely related to the markets you alluded to previously with France and the UK? Thank you.

Joacim Lindoff
24:28 - 26:33

Well, thank you, David. We are not foreseeing a bounce back in capital sales in Q4 based on the information we have today. We believe that we will have to navigate lower visibility and slower decision-making speed in Western Europe and some other global markets. Also in Q4 and some quarters to come, as I said in my presentation, it is difficult to know when, so to say, the spend level will be back to the levels that we have expected. Again, as I said, the interest to invest is there. It's just the allocation of funds from state budgets that needs to occur. I can't judge how long this will take, but it's obviously something that we continue to navigate. And as I said, we are not losing market shares. Rather the opposite. We are well positioned in these countries. On top of that, we continue to see good development in our rental and service businesses, both in Western Europe and other parts of the world. The political environment. I mean, I believe that it's fairly clear what is happening in the UK. We are expecting a budget proposal to be released at the end of this month, where we anticipate nothing less than an intention to continue investing in the NHS in the UK, which will be positive for us in the long term. But then it's obviously a question of getting those funds from the paper to the actual investment side, and it's difficult to say how long that will take. France, still forming a government, and getting a clear picture about the financial environment will probably take a few weeks or months more. And until then, we are expecting low visibility on when to get capital sales going again in France in the way that we want. We are selling capital equipment in France, but we aim to achieve a higher level.

Unknown 1
26:33 - 26:34

Obviously.

Joacim Lindoff
26:34 - 26:44

Netherlands has the same type of issue when it comes to, uh, yeah, I'll stop there, David, and see if there are any additional questions.

Unknown 2
26:45 - 27:18

Uh, yeah. Yeah. Uh, thank you for that. Then, you know, perhaps on the gross margin, with this lower utilization that you're expecting and with the visibility you have now on the product mix, do you still think that you're able to drive the improvements that you're expecting on the gross margin? I think for Q4, you know, we ended Q4 very strongly here. Uh, looking back a year. So do you expect to see improvements then, exiting the year?

Joacim Lindoff
27:19 - 28:03

If you take all factors into consideration, both the fact that we have most probably negative transaction effects impacting the gross margin side also in Q4, and we have significantly lower capital volumes and value in Q4 of this year than we had last year, which results in a negative product mix. And the fact that it takes some time to adjust our cost base in the supply chain. I believe that we will see sequential improvement, obviously, from Q2 into Q4, but it will not be improvements on the gross margin compared to where we were last year in Q4.

Unknown 2
28:05 - 28:24

Okay. Then, just one last question from me. I think about the cost initiatives that you are taking. Are you able to quantify the expected cost takeouts from these actions? And do you expect these to have an effect by this year? Will this be more tilted towards 2025? Thank you.

Joacim Lindoff
28:25 - 29:09

Yes. I mean, what we are doing is that we are continuing. We already had a fairly substantial amount of activities ongoing focused on continuous improvement, both in our opex and also in our supply chain. But obviously, given the situation in the markets where we are seeing a downturn in capital sales, we will need to make adjustments. Also on the OpEx side and in other areas, I would not be able to quantify the amount right now, but I am very much expecting that we will see our OpEx to net sales have a steeper downward trend than what we initially thought, but the effects will only be visible from 2025 onwards as it takes time to implement these changes.

Unknown 2
29:11 - 29:13

Okay. Thank you. Those are my questions.

Operator
29:17 - 29:23

The next question comes from Matthias Gadsdon from CIB. Please go ahead.

Unknown 3
29:26 - 29:57

Hello and good morning. Thanks for taking my questions. I have two questions. So the first one, I guess, would be on sales ahead as well. I mean, rental is solid and service as well. But for how long do you think you can sustain the strength in service without really improving momentum in capital sales? So I guess the question is related to service in that respect, because I guess that will come down if capital sales don't improve.

Joacim Lindoff
29:59 - 31:29

Yes, that's a good question, but fortunately for us, I don't believe the effects will be negative. Um, if you look over ten years, most probably, Matthias, but not in the short or mid-term when it comes to service. We still have a significant amount of under-penetration when it comes to our service regarding our current installed base. And we have a lot of work to be done on the service side when countries are not spending on capital. We, as we have been discussing before, observe a reversed effect where there is a greater need to service equipment. And if we have lower visibility on capital in the coming quarters, we will continue to see good development of our service business also in 2025 and 2026, which we will do anyway. So I have good hopes that, based on what I see today, service will continue to grow even with the decline of capital sales, and we will probably see service growth slightly quicker. Rental, as you say, shows stable growth, and our largest rental market, the US, has, as I mentioned during the call, secured further implementations. We are foreseeing good growth in rental also in 2025, very much driven by the US market.

Unknown 3
31:32 - 31:54

That's all clear. Sorry for the noise around me. The next question is on the comments regarding better capital trends in the US. Should we interpret this as supportive for Q4, or is it primarily a comment that will bolster the trends you foresee in 2025 in terms of sales volumes? That's the next one.

Joacim Lindoff
31:55 - 32:55

We will have good growth as far as the information we have today and how we see it, and we will experience good growth in the US in Q4. We are trending well on transactional sales, especially in patient handling. We are securing, I would say, more or less the first Outcome Programs in patient handling going into Q4; services are developing well, and rental is developing well. Growth in the US is anticipated for Q4 as well. Um, and obviously then also going into 2025, which is really good to see. With the new management in place and the changes that we have made, I believe that we have good momentum organizationally in the US. And so, no red flags currently, we can always be better, and we need to be better in the US. We're going to continue to work very hard on improving from that position. But there are positive signs in the US right now.

Unknown 3
32:57 - 32:58

Thank you very much.

Operator
33:05 - 33:12

The next question comes from Christopher Liljeberg from Carnegie Investment Bank. Please go ahead.

Unknown 4
33:13 - 33:27

If you follow up, sir, on the previous questions. First, I wonder how much visibility do you think you have to grow at least 3% in Q4, which you would need to reach at least the lower end of the financial target?

Joacim Lindoff
33:30 - 33:53

If I may say so. Enough visibility. Christopher, I think we are, as we always do, having very tight follow-ups with countries in a situation like this. We have obviously even tighter follow-ups with those countries to ensure that we understand the development and can take the appropriate mitigating actions or request the necessary mitigating actions. I believe that we.

Unknown 1
33:53 - 33:54

Yeah.

Joacim Lindoff
33:54 - 34:38

We are as well informed as we can be. We have good traction in service, we have good traction in rental, and the US market is continuing to develop favorably. Where we have weakness is in capital sales in Europe and some of our markets in the rest of the world. And there we believe that we have captured the possible downsides. And it's about now ensuring that the products we have in our pipeline are pushed over the line for year-end. But yes, I do believe that we have enough information to say that we're comfortable having a Q4 that is within the 3 to 5% interval. That helps us to get within the interval of 3 to 5% for the full year.

Unknown 4
34:41 - 35:03

And then I just wonder what has happened here since the last time you reported. You sounded quite confident then that the weakness in Europe was only temporary. You talked about the elections in the UK and France, and now it seems, listening to what you're saying, it seems more structural than before.

Joacim Lindoff
35:04 - 36:37

A structural issue was not identified. I'm not really sure because I still believe that there is a huge investment need in many of those European markets that we spoke about. And so, that will not go away and cannot be solved in other ways. So I don't think that we have a structural problem. What we do have is a budgetary problem in these major European countries. What has happened since we spoke after the Q2 report is clearly a continued weakness that we did not anticipate when moving into Q3, particularly around capital sales. To shed some light on that, between the end of Q2 and now, after Q3, we have approximately 100 million less in capital sales than what we expected at that time. And those are spread out from France, the Netherlands, and the UK, but also a Chinese business that last year actually saw some really good projects, and this year, more or less nothing. We also thought that the EU funds in Poland would provide us with an opportunity to grow already in Q3, which has not been the case. And there, we know that money will come in and help us growth-wise from Q4 onwards. But it is, I would say, a misinterpretation. Um, if you could put it like that, the development of the capital market and how service and rental are performing better than what we expected.

Unknown 4
36:37 - 36:48

But that means if I compare with what you said after the second quarter, obviously you have a much more cautious view on capital sales here for Q4.

Unknown 1
36:48 - 36:49

That is correct.

Joacim Lindoff
36:49 - 36:50

That is correct.

Unknown 4
36:50 - 37:02

Okay. Thanks. And then your previous comment on the gross margin not improving year over year. Should we even expect the gross margin to be lower in Q4 this year compared with Q4 last year?

Joacim Lindoff
37:03 - 37:04

I believe so, yes.

Unknown 1
37:04 - 37:05

Given the.

Joacim Lindoff
37:05 - 37:13

I believe so, given the product mix with less capital and the headwinds of currency, I would estimate that.

Unknown 1
37:13 - 37:15

But yes, I do believe that we have enough information to say that we're comfortable having a Q4 that is within the 3 to 5% interval. Okay.

Unknown 4
37:15 - 37:25

And then for the full year, does this mean a more flattish gross margin, or do you still expect to be able to improve it for the full year?

Joacim Lindoff
37:26 - 37:38

Yeah. Again, we don't necessarily guide on that one. Given a lower development in Q4, I believe the assumption that we will be just slightly better than last year is probably a good one.

Unknown 1
37:39 - 37:40

Okay.

Unknown 4
37:41 - 38:00

Great. And then my final question, on the financial net here with lower interest rates going forward, could you give some sort of indication where you expect that to be in Q4 and maybe the run rate when we move into 2025? Thank you.

Niclas Sjöswärd
38:01 - 38:38

Yes. No matter what, we see lower average interest rates now coming into our funding. Some of that is already visible in Quarter 3, but we will see more of it coming in Quarter 4. From a sequential perspective, we should see lower interest and finance net in quarter four. I think I will stop saying that, of course, we believe that next year that trend will continue. But it's of course dependent on the market pricing of interest rates. But we have certainly peaked in our interest rates, as we see it.

Unknown 4
38:39 - 38:40

Okay. Thank you.

Operator
38:51 - 38:58

The next question comes from Sten Gustafsson from ABG Sundal Collier. Please go ahead.

Unknown 1
39:00 - 39:01

Yes.

Unknown 5
39:01 - 39:19

Good morning. A question on the re-examination of capital goods sales here in Europe. Could you remind me how much of total sales typically would be related to capital goods in Western Europe. Um.

Joacim Lindoff
39:22 - 39:43

Oh, that's, uh. I was about to say that that's something you can read in the quarterly report because I don't have the exact number myself for the group. In total, it's around 40% of our turnover. That is capital goods. The rest comes from consumables, services, and also our rental business.

Unknown 5
39:44 - 39:56

But it is. Indeed, we can see the total there. But for Western Europe, is that more or sort of on average with the global average?

Joacim Lindoff
39:56 - 40:29

I would probably say it's slightly less than the global average because we have a bigger service business, and a bigger rental business, compared to the rest of the world. But on the other hand, you have kind of the same mix in the US and kind of the same mix in Canada. So I would say, without knowing exactly. It's around the group average again.

Unknown 5
40:29 - 40:39

Okay. And how much do you need in order to reach the full year guidance here of 3 to 5%?

Joacim Lindoff
40:40 - 41:19

Well, what we need to do for the full year guidance is obviously to execute on the realistic pipeline that we have for Q3, Q4, both in terms of our book-to-bill service and rental, and in our capital business. And as I said, in my view, we do have enough visibility to say that from the current standpoint, Q4 will have growth within the interval of 3 to 5%, probably more in the lower range of that, which will then keep us within the interval of 3 to 5% for the full year.

Unknown 1
41:20 - 41:21

Okay.

Unknown 5
41:22 - 41:38

Secondly, you talk about Arjo Insight and perhaps you can share with us what, you know, what kind of potential do you see in that one? And when will that start to really materialize into your numbers?

Joacim Lindoff
41:40 - 43:27

Yes, it is. Arjo Insight is already materializing into our patient handling numbers. And that is one of the reasons why we continue to see patient handling becoming more and more important for us, which is obviously going to be good. Also, from a product mix perspective, you should see the Insight project as kind of a middle step in our journey from transactional sales to really pure Outcome Programs, where we believe that within Insight we help the customer to realize value, but not necessarily implementing a full Outcome Program, which is also helping out in transactional sales in countries where we are significantly more tender-driven. So if you look at zero being transactional sales and one being the outcome, the insight program helps us maneuver together with the customer along that line to create value. So it is a way of helping the customer to understand what type of needs they have, how they can best, over time, exchange and replace and add new products, and how they can work with those products in a more efficient way. So it's a step on the way to a fully implemented outcome program, something that we very much believe will help a lot of the markets going forward. We are currently implementing in European markets, and we are looking forward to implementing our insight in the US at the beginning of the year. And for you, insight is one of the reasons why we have such good growth in Canada. As an example, in patient handling. So it's there, and I believe it will be a key tool for us going forward to ensure that we have continued good growth, especially on our patient handling side.

Unknown 1
43:28 - 43:28

Okay.

Unknown 5
43:28 - 43:31

Thank you. I'll get back to the line.

Operator
43:36 - 43:42

The next question comes from Richard Andy Kranz at Handelsbanken. Please go ahead.

Unknown 6
43:46 - 44:01

Good morning, and thank you for taking my questions. Could you elaborate a bit more on the further cost reduction initiatives, particularly the magnitude of the impact and timing, and maybe a bit more on where you're specifically looking to reduce costs? Thank you. I'll start there.

Unknown 1
44:02 - 44:03

Yep.

Joacim Lindoff
44:03 - 44:18

Um, if I start with the final part of your question, we are focusing on opex. Obviously, when it relates to the areas where we are seeing lower capital sales and where we.

Unknown 1
44:18 - 44:19

Believe.

Joacim Lindoff
44:19 - 45:29

That we need to make adjustments in our structure to better suit the capital levels that we have. We obviously are cautious to ensure that we are not cutting where we believe there is an opportunity and possibility for a change of trend in the short term. And as I said earlier, we cannot quantify the exact numbers right now, but what we do know is that the activities we are going to drive will help reduce our cost of goods sold and positively impact our opex trend versus net sales. So, it will also provide us with the possibility, even with lower capital volumes, to ensure that we set ourselves up for increased profitability from 2025 onwards. If we're now looking at 2024 with more moderate improvements than what we initially thought, I believe that we will, based on these activities. We aim to achieve a better improvement in profitability from 2025 onwards, both from a cost perspective and from an opex perspective.

Unknown 6
45:32 - 45:57

All right. Very clear. And then follow up. How is the progress going with the new product launches in Q4 and into next year and into 2026? And how does the new rollout and the acceleration of new products sort of align with cost cutting? It sounds like, you know, two different forces, I guess, in terms of accelerating the new launches there. Maybe you can elaborate a little bit.

Joacim Lindoff
45:58 - 46:54

Yes. We are not making changes to our R&D and product launches. That is something that is now tracking well after the external and new internal structures that we have. So our intention is not to touch that part. We believe that we will have a good structure on that point going forward. We're looking forward to the launch. That is in a very active phase around new hygiene solutions and new bathing solutions, and we're looking forward to launching new products in patient handling and pressure prevention at the beginning of next year. Currently, all is on the plans that we had from, let's say, the beginning of Q2 of this year. So that is running well. We are not cutting there, and I don't think that we should. We are obviously always looking into doing things more efficiently. But here, it's about making sure that we have enough resources to continue to drive a positive portfolio update.

Unknown 6
46:56 - 47:05

Very clear. And just a quick final one. Was it correct that there was roughly a one percentage point tailwind from price on the topline in the quarter?

Joacim Lindoff
47:07 - 47:14

We are currently, year to date, trending at around one percentage point on our organic growth from price.

Unknown 1
47:16 - 47:17

Okay.

Unknown 6
47:17 - 47:18

Thank you for taking my questions.

Operator
47:26 - 47:33

There are no more questions at this time, so I hand the conference back to the speakers for any closing comments.

Joacim Lindoff
47:34 - 48:16

Thank you, and thank you for joining in on this Q3 earnings call. A quarter with 1.5% organic growth headwinds, obviously being capital sales mainly in Europe, but also in some of the countries in the rest of the world. Good continued development of our service business, good continued development of our rental business, and the North American market that continues to see traction in the right direction. So we are heading into Q4 with high activity and are going to do everything we can to continue to grow the group in a profitable way going forward. Thank you.

Continue to the webcast
Revenio Group Oyj, Q3'26
Language: English11/12/2026, 1:00 PM
Jukka Kainulainen Good afternoon, and welcome to the Revenio Group Corporation Q3 Earnings Call. My name is Jouni Toijala. I am the CEO. And then, again today we have Jukka Kainulainen, our CFO, on th…
Kamux, Q3'26
Language: English11/12/2026, 9:00 AM
Katerina Heterant Good morning. Welcome to the Kamux Q3 results presentation. My name is Katerina Heterant and I am Head of Investor Relations at Kamux. Today we shall go through the Q3 results presen…
Koskisen, Webcast, Q3'26
Language: Finnish11/12/2026, 8:00 AM
Jukka Pahta Hyvää huomenta ja tervetuloa tähän osavuosikatsaustilaisuuteen! Koskisen tammi–syyskuun osavuosikatsaustilaisuuteen lähdetään otsikolla: Koskisen liikevaihdon kasvu jatkui. Kohonneet kusta…
Reaktor, Q3'26
Language: Finnish11/11/2026, 9:00 AM
Pekka Horo Oikein hyvää aamupäivää kaikille ja tervetuloa tähän meidän webcastiimme. Olen Pekka Horo, Reaktorin toimitusjohtaja, ja kanssani täällä on tänään Antti Akkanen, joka aloitti lokakuussa Rea…
Savox, Q3'26
Language: English11/10/2026, 11:00 AM
Paulina Tanila Our speakers today are CEO Jerry Kettunen and CFO Juha Järvi. Jerry will give an overview of Savox as a company and go through the highlights of the quarter. After that, Juha will conti…
Raisio Oyj, Webcast, Q3'26
Language: Finnish11/10/2026, 10:00 AM
Elli Siltala Hyvää marraskuista päivää Raisiosta! Ja tervetuloa Raision tammi-syyskuun 2026 osavuosikatsauksen webcastiin! Pahoittelut pienistä teknisistä haasteista, mitä meillä oli tässä alussa. Min…
Mandatum Oyj, Audiocast, Q3'26
Language: English11/10/2026, 9:00 AM
Lotta Borgström Good morning, everyone, and welcome to the Mandatum Q3 2026 audiocast. My name is Lotta Borgström from Investor Relations. Joining me today are our CEO, Petri Niemisvirta, and our CFO,…
Solar foods Go-to-market Update
Language: English11/9/2026, 12:00 PM
Maria Hello everyone, and welcome to the Solar Foods go-to-market update. My name is Maria and I'm here today with our CEO, Rami Jokela, and CFO and Deputy CEO, Ilkka Saura. Also with us today is Heli…
Outokumpu, Webcast, Q3'26
Language: English11/6/2026, 12:30 PM
Johan Welcome to the third quarter results webcast. I am responsible for investor relations. We will start with the presentation from our CEO, Kati ter Horst, and our CFO, Marc-Simon Schaar. After the…
Endomines, Webcast, Q3'26
Language: English11/5/2026, 1:00 PM
Andy Turpin Hello, everyone, and welcome to Endomines' third-quarter results webcast. Thanks for joining us today. My name is Andy Turpin and I am the Chief Communications Officer here at Endomines. A…
Lemonsoft Oyj, Q3'26 webcast
Language: English11/5/2026, 11:00 AM
Unknown 1 Welcome to the Lemonsoft Q3 results presentation. We will start with the presentation from CEO Alpo Luostarinen, followed by the Q&A. You can send your questions throughout the event via the…
Enersense, Webcast, Q3'26
Language: English11/5/2026, 10:30 AM
Liisa Tamminen Hello and welcome to the Enersense Q3 2026 results webcast. My name is Liisa Tamminen from Enersense Investor Relations. And with me here I have our CEO, Kari Sundbäck, and CFO, Jan-Elo…
Sitowise, Q3'26
Language: English11/5/2026, 10:00 AM
Mari Reponen Good day everyone, and welcome to the Sitowise Q3 2026 results audiocast. My name is Mari Reponen, and I am responsible for strategy and IR here at Sitowise. And today with me are our act…
Orthex, Webcast, Q3'26
Language: English11/5/2026, 9:00 AM
Alexander Rosenlew Good morning and welcome to the Orthex Interim Report. My name is Alexander Rosenlew and with me I have Saara Mäkelä, CFO, and Hanna Kukkonen, our CMSO. We will take you through the…
Suominen Oyj, Q3'26
Language: English11/5/2026, 8:30 AM
Anni Luoma Good morning, everyone, and welcome to the Suominen Q3 webcast. My name is Anni Luoma. I am the Manager of External Communications and Investor Relations at Suominen. Here with me are our P…
Lumo, Webcast, Q3'26
Language: English11/5/2026, 8:00 AM
Niina Saarto Good morning, all. Welcome. This is Lumo Homes plc's third quarter result webcast. I am Niina Saarto from Treasury and Investor Relations. Today I have two gentlemen here with me, namely…
CapMan, Webcast, Q3'26
Language: English11/5/2026, 7:30 AM
Charlotte Good morning and welcome to this presentation of CapMan. Q3 2026 interim report. Presenting today we have Pia Kåll, CEO of CapMan. And after the presentation, we will have a Q&A session. You…
Marimekko, Webcast, Q3'26
Language: English11/4/2026, 12:00 PM
Anna Good afternoon. My name is Anna and I am the IRO of Marimekko. It is my pleasure to welcome you to our Q3 webcast. With me, I have our president and CEO, Tiina Alahuhta, who will walk you through…
Administer, Webcast, Q3'26
Language: Finnish11/4/2026, 9:00 AM
Kimmo Herranen Welcome to the Administer Q3 2026 interim report. Results. Meillä on se alkaa. I am Kimmo Herranen. Kalle Lehtonen. Also. Kaarina og. Yelken. Kalle Lehtonen En el coco. Madan. Parannus.…
Kempower, Webcast, Q3'26
Language: English11/4/2026, 8:30 AM
Unknown 1 Powering the planet. Kempower. We charge our planet for the better. By powering the electric movement. We enable quick and scalable EV charging solutions for everyone and everywhere. We ma…